Patent · US Active

Compounds

US9522134B2 · kind B2 · utility

0Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 18, 2016
Grant dateDec 20, 2016
Priority date
Expiry dateMar 18, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula (I):wherein R1 and R2 are as defined herein. In certain embodiments, the compounds of the present invention are inhibitors of RORγt and are useful in the treatment of diseases and conditions mediated by RORγt.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.